Forbeli s.r.o.

Prague 165 00

3 studies enrolling now · 14 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease Dementia, Alzheimer's Disease Psychosis, Amyotrophic Lateral Sclerosis, Episodic Migraine, Focal Epilepsy, Focal Onset Seizures, Migraine, Mild Cognitive Impairment Due to Alzheimer's Disease, Mild to Moderate Alzheimer's Disease, Motor Neuron Disease

Studies at this site

• ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
• A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine — Recruiting now
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine — Completed
• Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. — Completed
• Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS — Stopped early
• MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments — Completed
• Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients — Completed
• A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease — Paused
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed